Passage Bio, Inc. [PASG]

Source: 

Company Overview

Passage Bio, Inc. is a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions.